Smith & Nephew to acquire Osiris Therapeutics for $660M
Smith & Nephew agreed to buy Osiris Therapeutics for about $660 million in cash to gain regenerative skin and wound products.
Productsregenerative skin and wound products
“Smith & Nephew Plc agreed to buy Osiris Therapeutics Inc. for about $660 million in cash to gain regenerative skin and wound products.”news.bloomberglaw.com
- 4 sources
- news.bloomberglaw.comSmith & Nephew to Buy Osiris in $660 Million Skin Products DealMarthe FourcadeMar 12, 2019
- innovahealthpartners.comSmith & Nephew Announces Two Acquisitions | InnovaHealth PartnersMar 13, 2019
- sec.govSMITH & NEPHEW PLC Form 6-K filed April 1, 2019Apr 1, 2019
- smith-nephew.com20190417 SN Completes Acquisition of Osiris Therapeutics IncApr 17, 2019
Summarized from public sources; check the original articles before acting on it.